MedPath

Maternal cardiac effect of Hydroxyethyl Starch (HES) using LiDCO in cesarean sectio

Phase 4
Completed
Conditions
pregnancy requiring caesarean section
cardiac effect
Anaesthesiology - Anaesthetics
Reproductive Health and Childbirth - Childbirth and postnatal care
Cardiovascular - Other cardiovascular diseases
Registration Number
ACTRN12616000252415
Lead Sponsor
Guang Han
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
60
Inclusion Criteria

(1) primiparas who underwent elective cesarean section (2)age of 20–30 years, (3) body weight of 60–90 kg, (4) ASA class 1–2, (5) no contraindications to spinal anesthesia.

Exclusion Criteria

(1) multiple pregnancy, (2) height less than 150 cm, (3) placenta previa, (4) complications including diabetes mellitus, hypertensive diseases in pregnancy, etc. (5) contraindication to central neural blockade (patients refusal, raised intracranial pressure, hypovolemic states, abnormal coagulopathy).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac output (CO) assessed using LiDCO rapid (arterial pressure waveform analysis).[Baseline (T0), immediately after spinal anesthesia (T1), skin incision (T2), neonates delivery (T3), the placenta delivery (T4), immediately after injection of oxytocin on uterine muscle wall (T5), end of operation (T6) ];Mean arterial pressure (MAP) assessed using LiDCO rapid (arterial pressure waveform analysis).[Baseline (T0), immediately after spinal anesthesia (T1), skin incision (T2), neonates delivery (T3), the placenta delivery (T4), immediately after injection of oxytocin on uterine muscle wall (T5), end of operation (T6) ];Stroke volume (SV) assessed using LiDCO rapid (arterial pressure waveform analysis).[Baseline (T0), immediately after spinal anesthesia (T1), skin incision (T2), neonates delivery (T3), the placenta delivery (T4), immediately after injection of oxytocin on uterine muscle wall (T5), end of operation (T6) ]
Secondary Outcome Measures
NameTimeMethod
nausea, assessed using 5-point Likert Scale[Every 10 minutes following spinal anaesthesia for 2 hours. ];headache, assessed using VAS pain score[Every 10 minutes following spinal anaesthesia for 2 hours. ]
© Copyright 2025. All Rights Reserved by MedPath